Clinical Trial Update: Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab plus cyclosporine for idiopathic membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy
• Nephrotic Syndrome

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Rituximab (rituximab)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Nephrotic Syndrome, Proteinuria | Phase 2 | Status: RECRUITING